Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial
@article{Kessler2008EffectOC, title={Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial}, author={H. Kessler and F. Pajonk and D. Bach and T. Schneider-Axmann and P. Falkai and W. Herrmann and G. Multhaup and J. Wiltfang and S. Schaefer and O. Wirths and T. Bayer}, journal={Journal of Neural Transmission}, year={2008}, volume={115}, pages={1651-1659} }
A plethora of reports suggest that copper (Cu) homeostasis is disturbed in Alzheimer’s disease (AD). In the present report we evaluated the efficacy of oral Cu supplementation on CSF biomarkers for AD. In a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial (12 months long) patients with mild AD received either Cu-(II)-orotate-dihydrate (verum group; 8 mg Cu daily) or placebo (placebo group). The primary outcome measures in CSF were Aβ42, Tau and Phospho-Tau. The… CONTINUE READING
43 Citations
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
- Medicine
- British Journal of Nutrition
- 2011
- 63
- Highly Influenced
- PDF
Copper Modulation as a Therapy for Alzheimer's Disease?
- Medicine
- International journal of Alzheimer's disease
- 2011
- 11
- PDF
Disturbed Copper Bioavailability in Alzheimer's Disease
- Medicine
- International journal of Alzheimer's disease
- 2011
- 30
- PDF
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis
- Medicine
- Journal of Neurology, Neurosurgery, and Psychiatry
- 2020
Anti-copper therapies in Alzheimer's disease: new concepts.
- Medicine
- Recent patents on CNS drug discovery
- 2009
- 16
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
- Chemistry, Medicine
- Front. Aging Neurosci.
- 2018
- 47
- PDF
Nutritional Strategies in the Management of Alzheimer Disease: Systematic Review With Network Meta-Analysis.
- Medicine
- Journal of the American Medical Directors Association
- 2017
- 13
Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease
- Psychology, Medicine
- Neurobiology of Aging
- 2011
- 25
References
SHOWING 1-10 OF 43 REFERENCES
Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial
- Psychology, Medicine
- Journal of Neural Transmission
- 2008
- 70
- PDF
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease
- Chemistry, Medicine
- Journal of Neural Transmission
- 2006
- 79
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease.
- Psychology, Medicine
- Journal of Alzheimer's disease : JAD
- 2005
- 75
Elevation of serum copper levels discriminates Alzheimer’s disease from vascular dementia
- Medicine
- Neurology
- 2003
- 49
Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment.
- Psychology, Medicine
- Archives of neurology
- 2004
- 28
- PDF
CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42
- Medicine
- The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
- 2003
- 111
Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
- Chemistry
- Neurobiology of Aging
- 2009
- 111
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
- Medicine
- Archives of neurology
- 2003
- 832
- PDF
Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
- Chemistry, Medicine
- Neuron
- 2001
- 1,261
- PDF